Arkolith/Insider Trading/TDOC/Form 4

Divita Charles III

CHIEF EXECUTIVE OFFICER, DirectorTeladoc Health, Inc. (TDOC) · full profile →Form 4 · filed Mar 12, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$152K
Net Open-Market Flow
-$152K
Transactions
6
3 non-derivative · 3 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 11, 2026Sell(S)28K$5.49$152K365K
Mar 10, 2026Option exercise(M)39K——367K
Mar 10, 2026Option exercise(M)25K——393K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Mar 10, 2026Option exercise(M)25K—$018K
Mar 10, 2026Grant(A)44K—$044K
Mar 10, 2026Option exercise(M)39K—$0196K

Transaction Codes

S
Open-market sale
M
Option exercise / conversion
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001347535-26-000004) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML